PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis

PURPOSE: Approximately 40% of metastatic melanoma patients develop brain metastases. Our purpose was to identify genes aberrantly expressed in melanoma that might be associated with propensity for brain homing. EXPERIMENTAL DESIGN: We studied gene expression profiles in a cell line model of brain me...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Jilaveanu, Lucia B., Parisi, Fabio, Barr, Meaghan L., Zito, Christopher R., Cruz-Munoz, William, Kerbel, Robert S., Rimm, David L., Bosenberg, Marcus W., Halaban, Ruth, Kluger, Yuval, Kluger, Harriet M.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4397107/
https://ncbi.nlm.nih.gov/pubmed/25316811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0861
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares